Key Takeaways
- • Prosper AI raised $30 million in Series A funding led by Andreessen Horowitz to expand its AI voice platform for healthcare automation, representing a significant escalation from its earlier $5 million seed round.
- • The company targets the $450 billion annual administrative burden in U.S. healthcare, automating patient scheduling, insurance benefit verification, prior authorizations, and claims management through specialized AI voice agents.
- • Prosper AI's agents have achieved measurable traction with major clients including a Providence-affiliated hospital (125,000 employees), a Fortune 50 pharmaceutical company, a 30,000-employee medical billing firm serving Top 10 U.S. health systems, and an EHR platform with 100,000+ medical providers.
- • The platform demonstrates deep integration with practice management and electronic health record systems, enabling AI agents to execute hundreds of thousands of calls and skip traditional IVR workflows while maintaining human handoff capabilities.
- • Revenue has grown 4x since Q2 2025, indicating strong market adoption and validation of the healthcare AI voice automation thesis among institutional healthcare buyers.
Summary
Prosper AI announced a $30 million Series A funding round led by Andreessen Horowitz, marking a substantial capital injection to scale its healthcare-focused AI voice platform. The funding builds on the company's earlier $5 million seed round, led by Emergence Capital with participation from Y Combinator, CRV, and Company Ventures, signaling sustained investor confidence in the healthcare AI automation sector.
The company addresses a structural inefficiency in U.S. healthcare: administrative staff comprise approximately one-third of the workforce in hospitals and physician offices, with annual administrative costs exceeding $450 billion. Much of this burden centers on routine but labor-intensive tasks—answering phones, calling insurers, processing claims, and managing prior authorizations—that create bottlenecks for both patient care and operational efficiency.
Prosper AI's platform deploys specialized AI voice agents that automate critical front-office and back-office healthcare workflows. Unlike generic voice AI tools, these agents are healthcare-specific, with deep integrations into practice management software and electronic health record systems. The agents can execute complex multi-step processes including patient scheduling, insurance eligibility verification, prior authorization requests, and claims follow-up, with the capability to navigate insurance hold times and transfer calls to human staff when appropriate.
The company has demonstrated significant commercial traction with enterprise healthcare clients. Its customer roster includes a Providence-affiliated hospital system with 125,000 employees, a Fortune 50 pharmaceutical company, a 30,000-employee medical billing firm serving top-tier U.S. health systems, and a leading EHR platform with more than 100,000 medical providers. Across these deployments, Prosper AI agents are executing hundreds of thousands of calls monthly. The operational impact has been measurable: the company reported 4x revenue growth since Q2 2025 alone, demonstrating accelerating adoption among institutional healthcare buyers.
The Andreessen Horowitz-led Series A capital will support accelerated development and deployment of advanced AI agents, further expansion of EHR and practice management integrations, and scaling operations to capture additional market share in the healthcare workflow automation segment.
The company addresses a structural inefficiency in U.S. healthcare: administrative staff comprise approximately one-third of the workforce in hospitals and physician offices, with annual administrative costs exceeding $450 billion. Much of this burden centers on routine but labor-intensive tasks—answering phones, calling insurers, processing claims, and managing prior authorizations—that create bottlenecks for both patient care and operational efficiency.
Prosper AI's platform deploys specialized AI voice agents that automate critical front-office and back-office healthcare workflows. Unlike generic voice AI tools, these agents are healthcare-specific, with deep integrations into practice management software and electronic health record systems. The agents can execute complex multi-step processes including patient scheduling, insurance eligibility verification, prior authorization requests, and claims follow-up, with the capability to navigate insurance hold times and transfer calls to human staff when appropriate.
The company has demonstrated significant commercial traction with enterprise healthcare clients. Its customer roster includes a Providence-affiliated hospital system with 125,000 employees, a Fortune 50 pharmaceutical company, a 30,000-employee medical billing firm serving top-tier U.S. health systems, and a leading EHR platform with more than 100,000 medical providers. Across these deployments, Prosper AI agents are executing hundreds of thousands of calls monthly. The operational impact has been measurable: the company reported 4x revenue growth since Q2 2025 alone, demonstrating accelerating adoption among institutional healthcare buyers.
The Andreessen Horowitz-led Series A capital will support accelerated development and deployment of advanced AI agents, further expansion of EHR and practice management integrations, and scaling operations to capture additional market share in the healthcare workflow automation segment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.